Corrected Q-T Interval Prolongation as Diagnostic Tool for Assessment of Cardiac Autonomic Neuropathy in Diabetes Mellitus
- Joyce M Gonin, MBChB,
- Mark M Kadrofske, BS,
- Steven Schmaltz, MPH,
- Edward J Bastyr III, MD and
- Aaron I Vinik, MD
- Department of Internal Medicine, the Division of Endocrinology and Metabolism, and the Department of Surgery, University of Michigan Ann Arbor, Michigan
- Address correspondence and reprint requests to Aaron I. Vinik, MD, University of Michigan Medical Center, 2922B Taubman Health Care Center, Ann Arbor, Ml 48109.
Abstract
A simple method for evaluating alterations in cardiac sympathetic innervation may be measurement of the Q-T interval. Seventy-three diabetic patients (46 insulin dependent and 27 non–insulin dependent) were separated into four groups based on the presence and degree of cardiac autonomic neuropathy (CAN) with noninvasive cardiovascular reflexes and blood pressure responses. None of the patients had evidence of ischemic heart disease, kidney disease, or the idiopathic long Q-T–interval syndrome. The corrected Q-T interval (Q-Tc) was determined at rest with Bazett's formula. As a group, diabetic patients with ≥2 abnormalities of cardiac autonomic function had a longer Q-Tc interval than those with no evidence of CAN. Diabetic patients with ≥1 abnormality had a prolonged Q-Tc interval compared with a control group of 96 healthy nondiabetic subjects (mean ± SD 397 ± 18). The frequency of prolonged (>433 ms, normal mean + 2SD) resting Q-Tc intervals increased with the increasing number of abnormalities (0, 1, 2, ≥ 3): 11, 25, 41, and 75%, respectively. Twenty-three of 25 (92%) patients with a Q-Tc >433 ms had evidence of CAN. However, 57% (31 of 54) of the patients with CAN had a normal Q-Tc interval. These data provide further evidence of a relationship between the presence and severity of CAN and degree of Q-Tc interval prolongation. Compared with cardiovascular reflexes and blood pressure tests for CAN, the Q-Tc interval in the group of diabetic patients studied without evidence of heart or kidney disease was an insensitive but specific marker. An abnormal Q-Tc interval may be an additional diagnostic tool for evaluating CAN in patients with diabetes mellitus.
- Received July 25, 1988.
- Revision received April 18, 1989.
- Accepted April 18, 1989.
- Copyright © 1990 by the American Diabetes Association











